发明名称 Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoid arthritis
摘要 <p>Citrulline (Cit) containing polypeptide (I) derived from all or part of the alpha - or beta -chains of fibrin (from a vertebrate) by substitution of at least one arginine residue by Cit, is new. Independent claims are also included for the following: (1) antigenic composition for detecting autoantibodies (AAb) specific for rheumatoid polyarthritis (RP), comprising at least one (I), optionally labeled and/or conjugated to a carrier protein; (2) method for detecting AAb; (3) kit for detecting AAb; and (4) pharmaceutical composition containing at least one (I) as active ingredient. ACTIVITY : Anti-arthritic; anti-inflammatory. No biological data is given. MECHANISM OF ACTION : Neutralization of an autoimmune response, especially inhibition of fixation of humoral/cellular effectors of the response. The antigen responsible for the autoimmune response in rheumatoid polyarthritis has been identified as citrulline-containing derivatives of fibrin chains.</p>
申请公布号 EP1619205(A1) 申请公布日期 2006.01.25
申请号 EP20050020523 申请日期 2000.06.30
申请人 BIOMERIEUX 发明人 SERRE, GUY;SEBBAG, MIREILLE
分类号 C07K14/75;G01N33/53;A61K38/00;A61P19/02;A61P29/00;A61P37/00;C07K14/47;G01N33/564 主分类号 C07K14/75
代理机构 代理人
主权项
地址